PH23584A - Piperidine compounds and pharmaceutical compositions containing the same - Google Patents

Piperidine compounds and pharmaceutical compositions containing the same

Info

Publication number
PH23584A
PH23584A PH35635A PH35635A PH23584A PH 23584 A PH23584 A PH 23584A PH 35635 A PH35635 A PH 35635A PH 35635 A PH35635 A PH 35635A PH 23584 A PH23584 A PH 23584A
Authority
PH
Philippines
Prior art keywords
piperidine compounds
same
pharmaceutical compositions
compositions containing
chem
Prior art date
Application number
PH35635A
Other languages
English (en)
Inventor
Leif Helth Jensen
Per Sauerberg
Frank Waetjen
Jens William Kindtler
Original Assignee
Ferrosan As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DK426986A external-priority patent/DK426986D0/da
Priority claimed from DK597186A external-priority patent/DK597186D0/da
Application filed by Ferrosan As filed Critical Ferrosan As
Publication of PH23584A publication Critical patent/PH23584A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Cephalosporin Compounds (AREA)
PH35635A 1986-09-08 1987-08-06 Piperidine compounds and pharmaceutical compositions containing the same PH23584A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK426986A DK426986D0 (da) 1986-09-08 1986-09-08 Piperidine forbindelser, deres fremstilling og anvendelse
DK597186A DK597186D0 (da) 1986-12-12 1986-12-12 Heterocykliske forbindelser, deres fremstilling og anvendelse

Publications (1)

Publication Number Publication Date
PH23584A true PH23584A (en) 1989-09-11

Family

ID=26067417

Family Applications (1)

Application Number Title Priority Date Filing Date
PH35635A PH23584A (en) 1986-09-08 1987-08-06 Piperidine compounds and pharmaceutical compositions containing the same

Country Status (17)

Country Link
US (2) US4837241A (fr)
EP (1) EP0259621B1 (fr)
JP (1) JPH0662616B2 (fr)
KR (1) KR950009366B1 (fr)
AT (1) ATE82751T1 (fr)
AU (1) AU603603B2 (fr)
CA (1) CA1340937C (fr)
DE (1) DE3782785T2 (fr)
ES (1) ES2043624T3 (fr)
FI (1) FI86424C (fr)
GR (1) GR3007053T3 (fr)
IE (1) IE62485B1 (fr)
IL (1) IL83275A (fr)
NO (1) NO169285C (fr)
NZ (1) NZ221672A (fr)
PH (1) PH23584A (fr)
PT (1) PT85650B (fr)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ219646A (en) * 1986-03-27 1990-10-26 Merck Sharp & Dohme Oxadiazole derivatives of azacyclics for treating cns disorders
GB8714789D0 (en) * 1987-06-24 1987-07-29 Lundbeck & Co As H Heterocyclic compounds
IL88156A (en) * 1987-11-13 1997-02-18 Novo Nordisk As Azacyclic compounds their preparation and pharmaceutical compositions containing them
EP0322034A3 (fr) * 1987-12-22 1991-01-02 Merck Sharp & Dohme Ltd. Tétrahydropyridylméthyl oxadiazoles
IL88846A0 (en) * 1988-01-08 1989-07-31 Merck Sharp & Dohme Lipophilic oxadiazoles,their preparation and pharmaceutical compositions containing them
DK162892C (da) * 1988-07-04 1992-05-11 Novo Nordisk As 1,2,5,6-tetrahydropyridinforbindelser, deres fremstilling og farmaceutiske praeparater indeholdende disse
US5260311A (en) * 1989-02-22 1993-11-09 Novo Nordisk A/S Piperidine compounds and their use
US5264444A (en) * 1989-02-22 1993-11-23 Novo Nordisk A/S Piperidine compounds and use
US5328925A (en) * 1989-02-22 1994-07-12 Novo Nordisk A/S Piperidine compounds and their use
US5043345A (en) * 1989-02-22 1991-08-27 Novo Nordisk A/S Piperidine compounds and their preparation and use
EP0459568A3 (en) * 1990-05-31 1992-09-30 Merck Sharp & Dohme Ltd. Substituted oxadiazoles and thiadiazoles for use in the treatment of glaucoma and novel compounds having such use
IE912760A1 (en) * 1990-08-06 1992-02-12 Smith Kline French Lab Compounds
DK198490D0 (da) * 1990-08-21 1990-08-21 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling og anvendelse
EP0561913B1 (fr) * 1990-11-29 1998-04-01 Allergan, Inc. Utilisation de derives de pyridine pour traiter l'hypertension oculaire
US5175166A (en) * 1991-08-27 1992-12-29 The University Of Toledo Muscarinic agonists
AU3171493A (en) * 1991-12-31 1993-07-28 Fujisawa Pharmaceutical Co., Ltd. Oxadiazole derivatives having acetylcholinesterase-inhibitory and muscarinic agonist activity
US5424301A (en) * 1993-02-01 1995-06-13 Warner-Lambert Company Starch stabilized o-substituted tetrahydropyridine oxime cholinergic agents
ATE180780T1 (de) * 1993-08-05 1999-06-15 Hoechst Marion Roussel Inc 2-(piperidin-4-yl, pyridin-4-yl und tetrahydropyridin-4-yl)-benzofuran-7-carbamat derivate, ihre herstellung und verwendung als acetylcholinesterase inhibitoren
US5753683A (en) * 1993-08-19 1998-05-19 Novo Nordisk A/S Antipsychotic method
US5605908A (en) * 1994-10-24 1997-02-25 Eli Lilly And Company Heterocyclic compounds and their use
US5929247A (en) * 1994-10-24 1999-07-27 Eli Lilly And Company Heterocyclic compounds and their preparation and use
US5998404A (en) 1994-10-24 1999-12-07 Eli Lilly And Company Heterocyclic compounds and their use
US5574028A (en) * 1994-10-31 1996-11-12 Eli Lilly And Company Method for treating anxiety
US5726193A (en) * 1994-10-31 1998-03-10 Eli Lilly And Company Method for treating anxiety
US5488056A (en) * 1994-10-31 1996-01-30 Eli Lilly And Company Method for treating anxiety
AU7639598A (en) 1997-05-29 1998-12-30 H. Lundbeck A/S Treatment of schizophrenia and psychosis
WO1999032486A1 (fr) * 1997-12-23 1999-07-01 Alcon Laboratories, Inc. Agents muscariniques et leur utilisation pour traiter le glaucome, la myopie, et d'autres dysfonctionnements
US6107313A (en) * 1998-10-02 2000-08-22 Combichem, Inc. Dopamine receptor antagonists
US7332508B2 (en) 2002-12-18 2008-02-19 Novo Nordisk A/S Substituted homopiperidine, piperidine or pyrrolidine derivatives
US20070185100A1 (en) * 2004-02-18 2007-08-09 Astrazeneca Ab Poly-heterocyclic compounds and their use as metabotropic glutamate receptor antagonists
EP1720874A4 (fr) * 2004-02-24 2010-03-03 Bioaxone Therapeutique Inc Derives de piperidine substitues en position 4
US8084473B2 (en) 2007-04-24 2011-12-27 Solvay Pharmaceuticals B.V. Heterocyclic compounds with affinity to muscarinic receptors
MX2009011499A (es) * 2007-04-24 2009-11-09 Solvay Pharm Bv Compuestos heterociclicos con afinidad por los receptores muscarinicos.
WO2009140483A1 (fr) 2008-05-15 2009-11-19 University Of Toledo Agonistes muscariniques servant de stimulateurs cognitifs
WO2012149524A1 (fr) 2011-04-29 2012-11-01 The University Of Toledo Agonistes muscariniques en tant qu'agents d'amélioration de la mémoire de travail et de la flexibilité cognitive
US10106525B2 (en) 2015-01-26 2018-10-23 BioAxone BioSciences, Inc. Rho kinase inhibitor BA-1049 (R) and active metabolites thereof
US10857157B2 (en) 2015-01-26 2020-12-08 BioAxone BioSciences, Inc. Treatment of cerebral cavernous malformations and cerebral aneurysms with rho kinase inhibitors
US10149856B2 (en) 2015-01-26 2018-12-11 BioAxone BioSciences, Inc. Treatment of cerebral cavernous malformations and cerebral aneurysms with rho kinase inhibitors
US11198680B2 (en) 2016-12-21 2021-12-14 BioAxone BioSciences, Inc. Rho kinase inhibitor BA-1049 (R) and active metabolites thereof
US10537567B2 (en) 2017-07-11 2020-01-21 BioAxone BioSciences, Inc. Kinase inhibitors for treatment of disease
US20220152005A1 (en) * 2019-04-04 2022-05-19 Andrew Coop Methods of using muscarinic antagonists in the treatment of depression

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3966748A (en) * 1975-05-08 1976-06-29 American Cyanamid Company Para-fluorophenyl-N-heterocyclic substituted butanes
US4518601A (en) * 1982-06-16 1985-05-21 Ciba Geigy Corporation 2-(3-Pyridyl)-1,3,4-oxadiazoles and use thereof in pest control
NZ219646A (en) * 1986-03-27 1990-10-26 Merck Sharp & Dohme Oxadiazole derivatives of azacyclics for treating cns disorders

Also Published As

Publication number Publication date
PT85650A (en) 1987-10-01
EP0259621B1 (fr) 1992-11-25
NZ221672A (en) 1990-09-26
US4837241A (en) 1989-06-06
AU603603B2 (en) 1990-11-22
IE872173L (en) 1989-03-08
IE62485B1 (en) 1995-02-08
EP0259621A2 (fr) 1988-03-16
FI86424C (fi) 1992-08-25
NO169285B (no) 1992-02-24
DE3782785T2 (de) 1993-04-01
NO873731D0 (no) 1987-09-07
GR3007053T3 (fr) 1993-07-30
FI873809A0 (fi) 1987-09-02
ES2043624T3 (es) 1994-01-01
JPH0662616B2 (ja) 1994-08-17
NO169285C (no) 1992-06-03
JPS6377877A (ja) 1988-04-08
KR950009366B1 (ko) 1995-08-21
IL83275A (en) 1994-02-27
NO873731L (no) 1988-03-09
AU7816587A (en) 1988-03-31
PT85650B (pt) 1990-05-31
FI86424B (fi) 1992-05-15
CA1340937C (fr) 2000-03-28
ATE82751T1 (de) 1992-12-15
US4933353A (en) 1990-06-12
FI873809A (fi) 1988-03-09
IL83275A0 (en) 1987-12-31
KR880003939A (ko) 1988-06-01
DE3782785D1 (de) 1993-01-07
EP0259621A3 (en) 1988-10-12

Similar Documents

Publication Publication Date Title
PH23584A (en) Piperidine compounds and pharmaceutical compositions containing the same
ZA877887B (en) Antibacterial agents-ii
EP0181001A3 (en) Polypeptide, a process for preparing the same, a pharmaceutical composition containing said polypeptide as well as the use thereof
GB8627698D0 (en) Therapeutic agents
AR245117A1 (es) Procedimiento para la preparacion de 6-metil-3,4-dihidro-1,2,3-oxatiazin-4-on-2,2-dioxido y sus sales asi como su purificacion.
DE3879429D1 (de) Cyclopropanderivate.
DK297485D0 (da) Carbapenemer med kvaternaere heteroarylalkylthio 2-substituenter samt laegemiddel indeholdende saadanne forbindelser
GB8706662D0 (en) Anti-arrhythmia agents
EP0099853A3 (en) 7-alpha-acylthio-15,16-methylene-3-oxo-17-alpha-pregna-1,4-diene-21,17-carbolactones, their preparation and use as medicinal agents
GR82015B (fr)
IL75430A (en) Pineapple ketone carbonate derivatives and their use as flavoring agents
DK444087A (da) Piperidinforbindelser, deres fremstilling og anvendelse
TW265342B (fr)